Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

NCT00697684 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndrome
Acute Lymphocytic Leukemia
Relapsed/Refractory Chronic Lymphocytic Leukemia
Relapsed/Refractory Non Hodgkin's Lymphoma
Hodgkins Disease
Relapsed Refractory Multiple Myeloma

Interventions

DRUG: Antithymocyte Globulin
DRUG: Clofarabine
DRUG: Clofarabine
DRUG: Clofarabine

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]